Ushbu ishga iqtibos qilgan ishlar

4 ta ish

Ish: Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

1. Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology

   Jinxin Dong, Denis Nikolenko, Shuxrat Boymuradov +2

   MaqolaCAR-T cell therapy researchClinical & Translational Oncology20264 iqtibos

   ABIABI:AkademIndex/2026.article.000172

2. Exploring cellular immunotherapy platforms in multiple myeloma

   Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

   MaqolaOAOchiq kirishCAR-T cell therapy researchHeliyon20241 iqtibos

   ABIABI:AkademIndex/2026.other.102962

3. Integrating RNA technologies with CAR-T cell therapy: strategies to overcome current limitations and expand clinical applications

   Alexey Yumashev, Matlyuba Sanoyeva, Emma Muradova +6

   Sharh maqola20260 iqtibos

   ABIABI:AkademIndex/2026.review-article.ndxz6ed7

4. Oncolytic virotherapy at the tumor microenvironment–CAR Therapy interface: Mechanisms, clinical translation, and future directions

   Ali M. Atoom, Jasur Rizaev, D. Polatova +5

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.057512